相关实验视频
Updated: Jul 12, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
克洛托和FGF-23在双相躁狂发作中的作用
B Sirlier Emir1, S Yildiz, A Kazğan Kiliçaslan
1Department of Psychiatry, Elazığ Fethi Sekin City Hospital, Elazığ, Turkey. brcsirlier@gmail.com.
克洛托和FGF-23的水平在患有双相情感障碍 (BD) 躁狂发作的男性中升高. 这些蛋白质可以作为BD的生物标志物和潜在的治疗点来管理躁狂发作.
科学领域:
- 生物化学 生物化学
- 精神病学是一个精神病学.
- 内分泌学 在内分泌学.
背景情况:
- 双极性障碍 (BD) 涉及炎症,其中包括Klotho和FGF-23.
- 疾病的病因在很大程度上是未知的,这促使人们对炎症标志物的研究.
研究的目的:
- 调查Klotho和FGF-23水平与双相情感障碍之间的关联.
- 探索Klotho和FGF-23作为BD躁狂发作生物标志物的潜力.
主要方法:
- 研究包括42名被诊断患有BD (躁狂发作) 的男性和41名健康对照.
- 社会人口统计数据,年轻狂热评分表和汉密尔顿抑郁症评分表被用于评估.
主要成果:
- 在患有BD躁狂发作的患者中观察到Klotho和FGF-23水平显著更高.
- 在Klotho/FGF-23水平和临床参数之间没有发现相关性.
- 已确定的切割值表明,对于这两种标记物,敏感性和特异性均为中度至高.
结论:
- 克洛托和FGF-23可能在躁狂发作病因学方面至关重要.
- 这些蛋白质是双相情感障碍的潜在候选生物标志物.
- 针对克洛托和FGF-23可以为BD提供未来的治疗策略.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
相关概念视频
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Psychosis: Goals of Pharmacotherapy
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...